Liver cancer study could help improve the safety of certain gene therapies for hemophilia

Research led by Randal J. Kaufman, Ph.D., has found that misfolded proteins in liver cells contribute to the development of liver cancer, shedding new light on the mysterious origins of one of the world's deadliest diseases.

Related Keywords

United States ,Randalj Kaufman ,Zhouji Chen ,Sanford Burnham Prebys ,Emily Henderson ,European Union ,National Hemophilia Foundation ,World Federation Of Hemophilia ,Molecular Therapy ,Sanford Burnham ,Discovery Industry Focus ,Glenn Pierce ,World Federation ,National Hemophilia ,Cancer ,Gene ,Liver ,Liver Cancer ,Bleeding ,Bleeding Disorder ,Flood ,Diet ,Gene Therapy ,Hemophilia ,Hemophilia A ,Hemophilia B ,Mh ,Protein ,Research ,Stress ,